# Pasithea Therapeutics Corp.: Form 8-K, filed Sep 9, 2026

- Company: [Pasithea Therapeutics Corp.](/companies/ktta.md) (CIK 1841330)
- Form: 8-K
- Filed: 2026-09-09
- Accepted by EDGAR: Sep 9, 2026, 16:20 ET
- Period: 2026-09-09
- Accession: 0001213900-26-098405
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841330/000121390026098405/ea0304934-8k_pasithea.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841330/000121390026098405/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841330/000121390026098405/ea0304934-8k_pasithea.htm

Filed Sep 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-098405. Last ingested by Listed: Nov 14, 2026, 23:46 ET. No prices; not investment advice.
